544 results on '"Gepstein, Lior"'
Search Results
2. Redifferentiated cardiomyocytes retain residual dedifferentiation signatures and are protected against ischemic injury
3. Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes
4. Utilizing Human-Induced Pluripotent Stem Cells to Study Cardiac Electroporation Pulsed-Field Ablation
5. Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome
6. Abstract 18867: A Novel Light-Sensitive Ex-Vivo Rat Atrial Anatomical Model for Studying Atrial Arrhythmias and Cardioversion
7. Abstract 18558: Modeling Cardiac Amyloidosis: Insights Into Pathogenesis and Therapeutic Strategies
8. Chemogenetics for Gene Therapy Based Targeted Cardiac Electrophysiological Modulation
9. Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies
10. Synthetic cells with self-activating optogenetic proteins communicate with natural cells
11. Ser194Leu DSG2 mutation, associated with arrhythmogenic left ventricular cardiomyopathy and ventricular tachycardia
12. Abstract 15219: Optogenetic “Printing” of Reentrant Arrhythmias in Human Induced Pluripotent Stem Cell Derived Cardiac Tissues
13. Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
14. Using Decellularization/Recellularization Processes to Prepare Liver and Cardiac Engineered Tissues
15. Is image integration with preprocedural CT a necessity?
16. Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell–Derived Cardiac Cell Sheets
17. Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes
18. 34 - Regenerative Medicine, CELL THERAPY, AND GENE THERAPY
19. The role of genetic testing in the prevention, diagnosis, and prognosis of sudden cardiac arrest in children
20. BS-454195-3 GENERATION OF A NOVEL IN-VITRO MODEL OF THE INFARCT BORDER ZONE TO STUDY HUMAN VENTRICULAR ARRHYTHMIAS
21. PO-455617-4 GENERATION OF A NOVEL IN-VITRO MODEL OF THE INFARCT BORDER ZONE TO STUDY HUMAN VENTRICULAR ARRHYTHMIAS
22. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
23. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
24. Use of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association
25. Elevated thrombin generation levels in the left atrial appendage in patients with atrial fibrillation
26. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: From molecular mechanisms to therapeutic targets
27. Embryonic Stem Cell Derivatives for Cardiac Therapy: Advantages, Limitations, and Long-Term Prospects
28. Abstract 18021: Combining Human Induced Pluripotent Stem Cell Derived Cardiac Sheets, CRISPR-Based Genome Editing, and Optical Mapping of Rotors to Study the Short QT Syndrome
29. Abstract 14583: Repeated Phenotyping and Arrhythmia Mapping of Human Induced Pluripotent Stem Cell Derived Cardiac Cellular-Sheets Expressing Genetically-Encoded Voltage Indicator
30. Embryonic Stem Cells for Myocardial Repair
31. PO-660-03 OPTICAL CONTROL OF ARRHYTHMIA MORPHOLOGY IN HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED CARDIOMYOCYTE CELL SHEETS
32. PO-617-03 OPTOGENETIC CONTROL OF REPOLARIZATION GRADIENTS IN HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED CARDIAC TISSUE
33. shRNAs Targeting a Common KCNQ1 Variant Could Alleviate Long-QT1 Disease Severity by Inhibiting a Mutant Allele
34. Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling
35. MP-470543-003 HIGH-THROUGHPUT SCREEN IDENTIFIES EVACETRAPIB AS CANDIDATE DRUG TO TREAT LONG QT SYNDROME TYPE 2
36. PO-CES-01 HIGH-THROUGHPUT SCREEN IDENTIFIES EVACETRAPIB AS CANDIDATE DRUG TO TREAT LONG QT SYNDROME TYPE 2
37. Importance of Ventricular Tachycardia Storms Not Terminated by Implantable Cardioverter Defibrillators Shocks in Patients With CASQ2 Associated Catecholaminergic Polymorphic Ventricular Tachycardia
38. ESTABLISHING A NOVEL MODEL TO STUDY CARDIAC ELECTROPORATION ABLATION UTILIZING HUMAN INDUCED PLURIPOTENT STEM CELLS
39. Redifferentiated cardiomyocytes retain residual dedifferentiation signatures and are protected against ischaemic injury
40. Optogenetic Control of Human Induced Pluripotent Stem Cell‐Derived Cardiac Tissue Models
41. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)
42. Contributors
43. 3D Cardiac Imaging of Electromechanical Coupling
44. A combined cell therapy and in-situ tissue-engineering approach for myocardial repair
45. Biologic Pacemakers: Past, Present, and Future
46. Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes
47. Left Ventricular Systolic Dysfunction Due to Atrial Fibrillation: Clinical and Echocardiographic Predictors
48. Abstract 13939: Triiodothyronine and Dexamethasone Enhances Electrophysiological Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
49. Abstract 14161: Drug Compounds Combination Screening Using Human Induced Pluripotent Stem Cell-Derived Cardiac Tissues
50. iPCS Cell Modeling of Inherited Cardiac Arrhythmias
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.